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Chapter I 
 
                General Introduction 
 
  Protein posttranslational modifications are essential in mediating protein 
biological functions in living cells [1, 2]. Protein posttranslational 
modifications include phosphorylation [3, 4], peptidyl-prolyl cis-trans 
isomerization and so on [5-7]. Peptidyl-prolyl (X-Pro, X means any amino acid) 
has cis and trans configurations in proteins [8]. In cis configuration, the 
dihedral angle (ω) formed by Cα-C-N-Cα+1 is about 0º, while ω is close to 180º in 
trans configuration. Trans configuration has less energy than cis [9] and thus 
trans configuration of the peptidyl-prolyl is dominant in proteins. However, 
there are still about 5.2-6.5% X-Pro peptide bonds with cis configuration in 
proteins [10-12]. Previous studies have demonstrated that peptidyl-prolyl 
cis-trans isomerization has a very important role in regulating numerous 
cellular processes containing protein folding, ligand selection, ion-channel 
gating, phage infection, structural stability maintenance, cellular signal 
transduction and so on [9, 13-15]. Given the significance of peptidyl-prolyl 
cis-trans isomerization, the detailed biological functions and catalytic 
mechanisms for peptidyl-prolyl cis-trans isomerization will be discussed in the 
following sections.  
 
1. The biological functions of peptidyl-prolyl cis-trans isomerization 
 
Peptidyl-prolyl cis-trans isomerization in protein folding 
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  Proline residue has only one hydrogen atom connected with nitrogen. When 
X-Pro peptide bond is formed, proline nitrogen has no hydrogen and cannot 
role as hydrogen bond donor in proteins. Therefore, proline acts as a disruptor 
for protein secondary structure [16]. In α-helix, hydrogen bond is formed by the 
amide group of one residue and the carbonyl oxygen of the sequentially fourth 
residue. Obviously, proline cannot exist in the middle of α-helix and often 
locates as the first residue of α-helix. In β-sheet, proline only roles as hydrogen 
bond acceptor. Proline often exists in β-turn [17, 18], which is used to connect 
the α-helix and β-sheet in the protein.  
  Due to the specialty of the proline residue in protein structure, 
peptidyl-prolyl cis-trans isomerization is critical for protein folding [19, 20]. 
Ribonuclease A has some folding phases and four prolines [19, 21-24]; thus, it 
is often used to study the relationship between peptidyl-prolyl cis-trans 
isomerization and protein folding. P93 and P114 are in the cis configuration of 
Ribonuclease A [25]. Trans configuration of P93 and P114 will alleviate the 
protein conformational folding ability, especially P93 with trans configuration 
resulted in drastic reduced folding rate [19, 21, 26]. Additionally, the 
conformational change for P117 from trans to the cis configuration in 
Ribonuclease A also affected the rate of protein folding [19, 21]. These studies 
have shown that peptidyl-prolyl with own unique arrangement is necessary for 
protein folding. Previous studies revealed that folding of some other proteins 
were also affected by peptidyl-prolyl cis-trans isomerization, such as 
Ribonuclease T1 [27, 28]. Wedemeyer and colleagues suggested that 
peptidyl-prolyl cis-trans isomerization destroyed the formation of hydrogen 
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bonds that was thought to be critical for protein structure and thus changed 
the protein folding rate [19].  
 
Peptidyl-prolyl cis-trans isomerization in ligand selection 
  Proline is commonly found in loops of proteins [29]. Some protein loops 
interact with ligands [30]. Therefore, it is possible that the proline is involved 
in interacting with ligands. The interaction between protein and ligands is 
dependent on hydrogen bonds, van der Waals forces, and other forces [31, 32]. 
Peptidyl-prolyl cis-trans isomerization could induce local structural and 
hydrogen bonds changes, thus may affect the protein-ligand interaction. 
Peptidyl-prolyl cis-trans isomerization may be one potential mechanism for 
regulating the protein-ligand interaction.  
  Src homology 2 (SH2) domain belongs to interleukin-2 tyrosine kinase (Itk) 
that participates in immune response [33-35]. NMR spectrum of SH2 domain 
showed that some residues sequentially or spatially close to P287 had both cis 
and trans configurations [33]; when P287 residue was replaced by glycine, 
NMR spectrum showed that P287G mutant had only one conformation [33]. 
Solution structure of SH2 domain showed that P287 was located in the loop of 
SH2, and indeed P287 had both cis and trans configurations in conformers [33]. 
Previous studies demonstrated that SH2 with P287 in the cis configuration 
preferred to interact with neighboring SH3 domain [36, 37] while SH2 with 
P287 in trans configuration favored the motif with phosphotyrosine [36]. It is 
proposed that peptidyl-prolyl cis-trans isomerization roles to mediate ligand 
selection as the molecular switch [33]. 
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Peptidyl-prolyl cis-trans isomerization in ion-channel gating 
  Ion channels are located at the cell membrane to regulate the ions to 
transfer into or out of cells. Living cells have more than 300 kinds of ion 
channels [38, 39], which are regulated by temperature [40, 41], pH [42-44] and 
other signals. Ion channels could be provided as one target for disease therapy 
[45, 46].  
  5-Hydroxytryptamine type 3 (5-HT3) receptor as an ion channel could be 
regulated by neurotransmitter [47]. There is a proline named P 8* existing in 
one loop connecting transmembrane helices [48]. NMR spectrum showed that 
some residues close to P 8* had both cis and trans configurations; mutation for 
P 8* resulted in functional loss of 5-HT3 receptor [49], which implied 
peptidyl-prolyl conformational change in this loop was related with 
ion-channel gating function [47]. It is proposed that when 5-HT3 receptor is in 
the open state for function, P 8* is in the cis configuration; while P 8* exists in 
trans configuration in the closed state of 5-HT3 receptor [47]. Peptidyl-prolyl 
cis-trans isomerization provides a unique insight to improve our 
understanding for ion-channel gating on the atomic level. 
   
Peptidyl-prolyl cis-trans isomerization in phage infection 
  Filamentous phage fd is one unusual virus that could infect Escherichia coli 
(E. coli) [50]. Gene-3-protein is found in the tip of phage, which was thought to 
be involved in infection for E.coli [50]. Gene-3-protein has two domains, named 
N1 and N2 domains that are connected by one hinge [51]. P213 is found in this 
hinge [51]. P213 residue was considered to affect N1 and N2 domains 
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interaction which was suggested to be important for infectious ability [52, 53]. 
It is proposed that when P123 is in the cis configuration, N1 and N2 domains 
will be close to each other, and the phage has no infectious ability; when P123 
is isomerized from cis to trans configuration, N1 and N2 domains will be far 
from each other, and the phage is functional [13, 53]. Hence, P213 cis-trans 
isomerization is proposed to regulate the infectious ability of the phage [53].  
 
Peptidyl-prolyl cis-trans isomerization in protein structural stability 
  Proteins execute biological functions depending on their unique structures. 
The structural stability is needful for the roles of proteins in cells. Previous 
studies have revealed there is a balance between structural stability and 
protein function [54]. Proteins with reduced structural stability are harmful to 
physiological processes, which could cause monogenic disease [55], Parkinson’s 
disease and so on [56]. Peptidyl-prolyl cis-trans isomerization has impact on 
protein structural stability [13].  
  Up to now, the importance of peptidyl-prolyl cis-trans isomerization for 
structural stability is testified in many proteins, such as Staphylococcus 
aureus nuclease [57], G protein-coupled receptor kinase 2 (GRK2) [58]. GRK2 
could phosphorylate the G protein-coupled receptor that is related with 
cellular growth, development and so on [59-61]. GRK2 has S670-P671 motif 
where S670 could be phosphorylated to form pS670-P671 [58]. Human Pin1 
promotes the degradation of GRK2 with pS670-P671 motif [58]. Pin1 is 
momentous for performing cis-trans isomerization of pSer/pThr-Pro motif [62]. 
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Thus, it is reliable that peptidyl-prolyl cis-trans isomerization affects 
structural stability of GRK2.  
 
Peptidyl-prolyl cis-trans isomerization in cellular signal transduction 
  Cellular functions are precisely regulated by kinds of proteins. These 
proteins form the huge network in the cells. Protein-protein interaction and 
protein-ligand interaction will transmit the outer simulative signals into the 
cells and thus cells response correctly. Proteins in cellular signal transduction 
pathways are affected by many factors, for example, peptidyl-prolyl cis-trans 
isomerization [13, 63, 64]. 
  Crk as a signaling protein is found to be overexpressed in many cancers [65, 
66]. Crk has two SH3 domains connected by one loop containing some proline 
residues [67]. Peptide bond between G237 and P238 plays an important role in 
regulating direction of both SH3 domains [67]. When peptidyl-prolyl of 
G237-P328 occupies cis conformation, both SH3 domains interact with each 
other, resulting in no functional state. Contrast, in the case of trans 
configuration, both SH3 domains are not close to each other, and Crk protein 
recovers the ligand binding affinity [67, 68]. Therefore, peptidyl-prolyl 
cis-trans isomerization mediates Crk protein function and thus controls the 
cellular signal transduction.  
 
2. The catalytic mechanisms of peptidyl-prolyl cis-trans 
isomerization 
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  Based on the above description, we know peptidyl-prolyl cis-trans 
isomerization is significant in living cells. Therefore, it is necessary to uncover 
the mechanism of peptidyl-prolyl cis-trans isomerization. It is known that 
carbon-nitrogen prolyl bond has partial double bond characteristics [69, 70]. 
The high barrier energy results in the slow process for cis-trans isomerization 
[71, 72]. The peptidyl-prolyl cis-trans isomerization is accelerated by 
peptidyl-prolyl cis-trans isomerases. Enzymes with isomerase activity are 
separated into cyclophilins, FK506 binding proteins (FKBPs), phosphotyrosyl 
phosphatase activator (PTPA) and parvulins [73-76]. The detailed catalytic 
mechanism regulated by isomerases remains controversial. In order to explain 
peptidyl-prolyl cis-trans isomerization, nucleophilic attack mechanism and 
twisting amide bond mechanism were hypothesized for isomerases. 
Nucleophilic attack mechanism was facilitated through the formation of 
covalent bond between active site cysteine residue and substrate carbonyl 
carbon; however, twisting amide bond mechanism was not assisted by the 
formation of the covalent bond [77-81]. Some peptidyl-prolyl cis-trans 
isomerases might adopt the twisting amide bond mechanism [82-84]. We will 
discuss peptidyl-prolyl cis-trans isomerization mechanism based on 
cyclophilins, FKBPs, PTPA and parvulin subfamilies in the following sections. 
 
Cyclophilins   
  Cyclophilins are widely found in many species, including mammals, bacteria 
and so on [85]. Here cyclophilin A (CyPA) is chosen as a representative for 
cyclophilins to discuss the peptidyl-prolyl cis-trans isomerization mechanism. 
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CyPA is known for binding cyclosporine A (CsA), which is a cyclic peptide 
inhibiting the lymphocyte activation [86-88]. Human cyclophilin A (hCyPA) 
could isomerize the peptidyl-prolyl bond in Itk and HIV-1 capsid proteins [36, 
89]. Fischer and colleagues thought cysteine residues in CyPA possessed a role 
in catalytic process as a nucleophile [86]. hCyPA has four cysteines, C52, C62, 
C115 and C161, respectively [90]. According to the nucleophilic attack 
mechanism [86], these four cysteines should interact with CsA covalently; 
however, replacement of every cysteine with alanine did not affect the affinity 
for CsA, which indicated that the role of cysteine thiol as a nucleophilic group 
in the catalysis was not taken [90]. The positions of four cysteines were not 
conserved in yeast CyP sequence whilst yeast CyP still had the detectable 
catalytic activity [90, 91]. Thus, it is speculated that cysteine residues have 
another role in CyPA instead of nucleophile. Values from secondary deuterium 
isotope effects for cyclophilin showed that carbonyl carbon did not rehybridize 
from sp2 to sp3 in the catalytic process, which eliminated nucleophilic attack 
mechanism [92-94]. It was hypothesized that twisting amide bond mechanism 
was accepted for hCyPA [81, 95] and R55 of hCyPA was suggested to role as 
hydrogen bond donor for proline nitrogen to facilitate the peptidyl-prolyl 
cis-trans isomerization [96], which was evidenced by that the replacement of 
R55 with alanine resulted in inactive catalytic function [97]. The role of 
cysteine residues in hCyPA remains elusive. To analyze the detailed function of 
cysteine residues will improve the understanding for peptidyl-prolyl cis-trans 
isomerization. 
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FK506 binding proteins 
  FK506 binding proteins (FKBPs) are known for binding FK506 that is a 
chemical molecule could inhibit lymphocyte activation [98-101]. Besides 
peptidyl-prolyl cis-trans catalytic function, FKBP of archaea had 
chaperone-like activities [102], which implied that FKBP might have dual 
function in the living cells. FKBP-12 is one human FKBP, interacting with 
Smad7-Smurf1 [103], which indicates peptidyl-prolyl cis–trans isomerization 
may possess a role in regulating Smad7–Smurf1 complex. Complex crystal 
structure of FKBP and FK-506 demonstrated five hydrogen bonds existed 
between them [104]. The ketone carbonyl in the FK506 was perpendicular to 
the peptide bond plane, different from the unbound form of FK506, indicating 
the twisting amide mechanism may be accepted [104]. However, the position of 
R55 in cyclophilin was not found in FKBPs. It is speculated that the amide 
group of the residue following proline acts as hydrogen bond donor to form 
intramolecular hydrogen bond with proline nitrogen to facilitate the 
isomerization [81].  
  
Phosphotyrosyl phosphatase activator 
  Phosphotyrosyl phosphatase activator (PTPA) regulates and activates PP2A 
and PP2A-like enzymes through isomerizing peptidyl-prolyl bond [105]. PTPA 
proteins are extensively discovered in various species, scattering from yeast to 
human [106, 107]. Crystal structures of human PTPA (hPTPA), yeast PTPA1 
(Ypa1) and yeast PTPA2 (Ypa2) have demonstrated that hPTPA, Ypa1 and 
Ypa2 have the similar folds, comprising of α-helix without β-sheet [108], 
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however, other three kinds of PPIases have β-sheets in their structural core [84, 
104, 109]. Complex crystal structure of Ypa1 and peptide demonstrates that 
peptide addition leads to forming Ypa1 protein dimer, and peptide is located in 
hydrophobic groove formed by dimer interaction [108]. The communication 
mode of PTPA and substrate is significantly different from other PPIases [108], 
especially ATP or analogues are not dispensable for PP2A activation [106, 107]. 
Although PTPA shows the importance and specialty, however, to date, the 
catalytic mechanism remains elusive.  
 
Parvulins 
  Parvulin was first discovered in E.coli [110], and other parvulin proteins 
were found subsequently in human [111], plant [112]. So far, about 10 kinds of 
parvulin protein have the published structures deposited in PDB: Pin1 [113], 
Par14 [114, 115] from human, Pin1At from Arabidopsis thaliana [116], Par10 
[117], SurA [118] from E. coli, Ess1 from Candida albicans [119], PrsA-PPIases 
from Bacillus subtilis [120] and Staphylococcus aureus [121], PinA from 
Cenarchaeum symbiosum [122], and TbPin1 from Trypanosoma brucei [123]. 
According to favored substrate specificity, the above 10 kinds of PPIases are 
divided into two parts: Pin1-type parvulin (Pin1, TbPin1 and Pin1At) that 
prefers phosphorylated substrate with pSer/pThr-Pro motif [113, 123, 124]; the 
other is non Pin1-type (Par14, Par10, SurA, PinA, and both PrsA-PPIases) 
prefers non-phosphorylated substrate [112, 121, 122, 125]. Comparison shows 
that parvulin proteins have significant structural changes among them. 
Pin1At, TbPin1, PinA, Par14, Par10 have only catalytic PPIase domain 
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relative to other parvulin proteins [114-117, 121, 122]. The fold of catalytic 
PPIase domains of all parvulins are same, comprising of four α-helices and four 
β-sheets; two β-sheets are in the center of the structure and surrounded by four 
α-helices [113-123]. In the structure of PrsA from Staphylococcus aureus, it 
was the first time that Heikkinen and colleagues found there was a charge 
relay system between His-His motif located in the structural core [121]. Based 
on the high resolution of Par14 crystal structure, it was concluded that 
extended Cys/Asp-His-His-Thr/Ser motif and corresponding hydrogen bonds 
were conserved in all the parvulin proteins with isomerase activity [126]. 
However, the detailed role of tetrad motif in the parvulins is still not known.  
  Human Pin1 is representative in parvulins. Pin1 consisting of 163 residues 
was first discovered in yeast research [111]. Pin1 protein is composed of two 
domains connected by a long linker, and one domain is N-terminal WW domain 
that is in charge of binding short proline-rich motifs of substrates; the other 
one is C-terminal PPIase domain whose catalytic mechanism attracted much 
attention in the past years [113]. The isolated WW domain showed 
disappeared isomerization ability, whilst the separated PPIase domain had 
90% catalytic ability relative to the full-length Pin1 protein [127]. Pin1 prefers 
substrate with the pSer/pThr-Pro motif [113], however, due to low binding 
ability of PPIase domain for substrate, to date; there is no published structure 
for PPIase domain with natural substrates containing pSer/pThr-Pro motif to 
study the catalytic mechanism. In view of the complex crystal structure of Pin1 
and short Ala-Pro peptide, nucleophilic addition mechanism was proposed for 
catalysis [113], similar with cyclophilin [86]. Pin1 has one cysteine in the 
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active site, called C113 [113]. Ranganathan and colleagues thought that the 
thiol of cysteine would attack the carbonyl carbon and form covalent bond 
between them to facilitate the isomerization of motif [113]. However, more and 
more evidences are against nucleophilic addition mechanism of Pin1. The 
cysteine does not seem to be essential as evidenced by that C113S and C113D 
mutant did not abolish catalytic activity [128]. Behrsin and colleagues 
suggested that C113 only maintained the overall electronegative environment 
for the substrate, which might prevent the formation of carbon-nitrogen double 
bond in the substrate [128]. However, this mechanism cannot explain the 
severely decreased catalytic activity of C113S and C113D because carboxyl in 
aspartic acid, hydroxyl in serine also could function to supply the 
electronegative environment for the isomerization process. One complex 
crystal structure of Pin1 and a specially devised inhibitor where carbonyl 
group was replaced by methylene that mimicked the twisted state of the 
substrate expressed that C113 sulfur was 4.6 angstrom distant from 
methylene carbon [84]. The structure also showed that the covalent bond 
between C113-S and carbonyl carbon was not formed in the catalytic process. 
Additionally, cyclohexyl ketone inhibitors showed weak inhibition of Pin1 [129]; 
Results from secondary kinetic isotope effects meant carbonyl carbon did not 
change from sp2 to sp3 in the catalytic process, which ruled out the nucleophilic 
addition mechanism [130]. Twisting amide mechanism was proposed for Pin1 
[130]. Twisting amide mechanism was assisted by inter or intra hydrogen 
bonds. Schroeder and colleagues suggested that H59 Nε2-H would role as 
hydrogen bond donor [77]. However, complex crystal structure of Pin1 and 
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substrate with twisted-amide state demonstrated that there was no hydrogen 
bond between proline nitrogen and Pin1 atoms, which indicated that the amide 
group of the residue following proline acts as hydrogen bond donor to promote 
isomerization. 
  Based on the above discussion, twisting amide mechanism may be 
hypothesized for some peptidyl-prolyl cis-trans isomerases. Nucleophilic 
addition mechanism was suggested in the initial studies of CyPA and Pin1 [86, 
113]. The reason is that CyPA and Pin1 have cysteine residue in the active site, 
and thiol group of cysteine could function as nucleophile. To date, nucleophilic 
addition mechanism was ruled out by mutagenesis, kinetic isotope effects. 
However, the role of cysteine in PPIases remains elusive. Replacement of 
cysteine resulted in decreased catalytic activity. Hence, it is necessary to 
uncover the role of cysteine in PPIases, and it will help us improve the 
understanding for detailed catalytic mechanism of PPIases.   
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Chapter II 
The C113D mutation in human Pin1 causes allosteric 
structural changes in the phosphate binding pocket of 
PPIase domain through the tug-of-war in the dual 
histidine motif 
 
Summary 
  Pin1 peptidyl-prolyl isomerase (PPIase) catalyzes specifically pSer/pThr-Pro 
motif. The peptidyl-prolyl cis–trans isomerization mechanism has been 
studied by various approaches, including X-ray crystallography, site directed 
mutation to identify the functionally relevant residues, and kinetic isotope 
effect on the isomerization. However, it still remains elusive. Preceding studies 
proposed that C113 in Pin1 has a catalytic role in the conformational 
transition process through its nucleophilic attack or hydrogen bonding to 
substrate carbonyl moiety. The fact that C113D mutant Pin1 does not abolish 
the activity challenges the importance of C113 as a catalyst. To facilitate our 
understanding on the Pin1 isomerization process, the structures and dynamics 
of the wild-type and C113D mutant Pin1 PPIase domains comprising the 
residues 51–163 were compared. We found that the C113D mutation disturbed 
the hydrogen bonds among the conserved histidine residues, H59 and H157 
(“dual histidine motif”); H59 imidazole forms a tighter hydrogen bond to H157 
in the wild type, whilst it has a stronger hydrogen bond to D113 in C113D 
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mutant. C113D mutation unbalanced the tug-of-war for H59, which eventually 
resulted in the altered active loop structure having basic triad residues (K63, 
R68 and R69) engaging in the phosphate binding. The active loop distortion 
could explain the severely reduced substrate binding of C113D mutant. This 
work demonstrated that C113 had a role in maintaining the catalytic site in an 
active fold, which has been never described before. 
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1. Introduction 
  Pin1 is a highly conserved peptidyl-prolyl isomerase (PPIase) that 
specifically catalyzes the cis–trans isomerization of pSer/pThr-Pro substrates, 
thereby regulating protein functions [131-133]. Pin1 catalyzes the intrinsically 
slow conversion of the peptidyl-prolyl bond from cis to trans and vice versa, 
thus “switches” their conformation, in coupled with protein kinases to 
Ser/Thr-Pro motif. The Pin1-mediating conformation changes following 
phosphorylation are believed to constitute novel transduction pathways in 
various phosphorylation-dependent signaling processes in cells. Disordering of 
Pin1 function, therefore, leads to pathogenesis of cancer and the protein 
folding diseases including Parkinson’s and Alzheimer’s diseases [134-136]. 
Pin1 interacts with some transcription factors that are phosphorylated in cells 
essentially roles in maintaining pluripotency of the induced pluripotent stem 
(iPS) cells and the embryonic stem (ES) cells [137].  
 Pin1 comprises of two domains; a catalytic domain functioning as PPIase 
and a WW domain that binds to pSer/pThr-Pro containing substrate [113]. The 
two domains are shown to interplay when Pin1 acts [138-140], whereas PPIase 
domain is solely responsible for isomerization activity. In fact, the isolated 
PPIase domain displays comparable or more activity relative to the full-length 
Pin1 [141], which assures the isolated PPIase domain can be used for the study 
of its enzyme mechanism.  
 Pin1 is a member of the parvulin family composing of a small PPIases. 
Parvulins are classified into two types in terms of substrate specificity; 
phosphospecific (Pin1-type) and non-phosphospecific (Par14-type) [142]; the 
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non-phosphospecific type parvulins consist of only PPIase without WW domain 
[143]. All parvulins share similar folds and conserved residues in the catalytic 
site in PPIase [113], which allow the structural comparisons among the 
parvulin PPIases for assessing the roles of each conserved catalytic site 
residues. The high-resolution crystal structure of human Par14 showed the 
four conserved residues have hydrogen bonding network running across the 
catalytic site [126]. The hydrogen bonding network by the four-residue motif 
(“catalytic tetrad”) in Par14 is supposed to be conserved among all parvulin 
family PPIases to maintain the folding of the catalytic site [126]. The catalytic 
tetrad in Pin1 consists of C113-H59-H157-T152 while the Par14 counterpart is 
D74-H42-H123-T118. The tetrad motif sequence is, thus, represented as 
Cys/Asp-His-His-Thr/Ser with inclusion of the variation at fourth residue in 
the parvulins [126].  
 Pin1 catalytic mechanism on the atomic level is not well understood. The 
proximity of C113 to the carbonyl in the bound Ala-Pro dipeptide in the Pin1 
complex crystal structure deduced the nucleophile attack catalysis by C113 
(Figure II-1A) [113]. The cysteine, however, does not seem to be essential, as 
evidenced by that C113D and C113S mutations did not abolish the activity 
(Figure II-1B) [128]. Moreover, the corresponding cysteine is replaced by an 
aspartate in Par14-type PPIases [115, 143]. In an alternative proposition, SH 
group of C113 makes the hydrogen bond to the carbonyl oxygen in the 
substrate to disrupt the carbon-nitrogen -bond of the amide to rotate easily 
[128]. This mechanism cannot clearly explain the severe activity reduction for 
C113S that replaces SH with OH, in considering that both groups can work as 
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hydrogen bond donors. An elaborate study using kinetic isotope effects 
demonstrated that twisting the amide bond formation lowers the transition 
energy for isomerization, which is facilitated by hydrogen bonding to prolyl 
nitrogen from the following residue amide proton in the substrate peptide 
[130]. The crystal structure of Pin1 with a reduced amide inhibitor bound in 
the active site showed the compound structure was close to the twisted amide 
supposed to be in transition state [84].  
 Molecular dynamics simulation gave the other insights into the cis–trans 
isomerization process. Hamelberg and co-worker applied molecular dynamics 
simulation to sample the entire conformation ensembles of the Pin1 substrate 
complex, with the corresponding relative binding free energies, during the 
cis–trans conversion of the substrate [144]. The theoretical work could assess 
the binding free energies in the substrate–Pin1 complex, which are not 
accessible experimentally, and showed Pin1 preferentially binds to transition 
state substrate having ω ≈ 90° over those in cis or trans states [144]. This 
observation is consistent with the twisted amide bond mechanism mentioned 
above [130].  
 Hamelberg’s group has also demonstrated that the PPIase domain of Pin1 
in free state samples significantly wider conformations than those for the 
complexes with cis or trans peptide substrate [145]. They proposed that Pin1 
adopt conformational selection in phosphorylated substrate recognition, with 
emphasizing the importance of intrinsic structural flexibility of Pin1 PPIase 
domain [145]. The functional relevance of the structural dynamics of PPIase 
domain is also emphasized experimentally: the conformation sampling may 
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change through the contact with WW domain in response to the substrate 
bound in the domain interface [138-140].  
 In this work, we explored the mechanism for the reduced activity of C113D 
Pin1 PPIase mutant with intention to improve our understanding how Pin1 
isomerizes. C113D mutant has arose controversial arguments against the 
proposed mechanisms. C113D mutant has the catalytic tetrad motif, defined as 
Cys/Asp-His-His-Thr/Ser, but the mutant showed severely reduced activity. 
Therefore, the proposed role of the hydrogen bonding network among the 
tetrad in precisely positioning Cys/Asp moiety [126] does not seem valid for 
Pin1. In addition, the mechanism assuming C113–substrate carbonyl 
interaction hardly explains that C113D mutant retains activity, although it is 
reduced; aspartate side chain cannot be a hydrogen bond donor as thiol group 
is at neutral pH [128]. Exploring why C113D mutant has reduced its activity 
will, therefore, give us newer insights into the isomerization mechanism of 
Pin1, which prompted us to work on C113D mutant Pin1 PPIase domain.  
 The present work has shown that the reduced activity of C113D is 
primarily ascribed to its reduced binding to phosphate moiety in the substrate. 
The reduced binding could be explained by the deformed active loop 
comprising of three basic residues (K63, R68 and R69) that directly bond to 
phosphate, as evidenced by NMR structures of C113D and wild-type Pin1 
PPIases. The hydrogen bonding network among two histidines (H59 and H157) 
within the tetrad motif was observed in both wild-type and C113D mutant 
Pin1 PPIase domains. The strengths of the hydrogen bonds, however, changed 
in the C113D mutation; H59 seems pulled to H157 in the wild type, whilst it 
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has a stronger hydrogen bond to D113 in C113D mutant. H59 is in the 
“tug-of-war” of the hydrogen bonding network between the residues at 113 and 
H157 among the catalytic tetrad. The unbalancing the tug-of-war by the 
mutation altered the active loop structure presumably by destabilizing the 
catalytic site fold. The structural destabilization by C113D mutation was 
apparent, as evidenced by the elevated chemical exchanges seen in the spin 
relaxation data and the increased H/D exchange rates for most of the residues 
in C113D mutant. We eventually emphasize that C113 roles in keeping the 
catalytic site in an active fold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 21 
 
2. Materials and methods 
2-1. Pin1 PPIase purification 
  The cDNA encoding the peptidyl-prolyl isomerase (PPIase) domain of human 
Pin1 (residues 51–163) [113] was cloned to the expression vector pET28a 
(Addgene). The recombinant plasmids were transformed to Escherishia coli 
strain BL21 (DE3) cells (New England Biolabs). The cells were grown in M9 
minimum medium at 37°C with 50 μg/ml kanamycin to an A600 of 0.6. For 
preparing the NMR samples, 15NH4Cl and 13C-glucose were used for nitrogen 
and carbon sources, respectively. The expression of the His6-tagged protein 
was induced by adding isopropyl-β-thiogalactopyranoside (IPTG) to a final 
concentration of 0.5 mM, and the cells were further cultured for 16 h at 18°C. 
Cells from a 1-liter culture medium were harvested and re-suspended in 100 
ml buffer solution (50 mM Tris-HCl, pH 8.0). The cells were broken by 
sonication and the soluble fraction was collected by the centrifugation at 
14,000 rotation per min (rpm) at 4°C for 20 min. Polyethylenimine was put 
into the supernatant to a final concentration of 0.1% to remove the DNA and 
RNA contaminants by applying another centrifugation at 14,000 rpm at 4°C 
for 20 min. The collected supernatant was applied to TALON® column 
(TAKARA Bio). After the flow through to the column with the buffer solution 
(50 mM Tris-HCl, pH 8.0), the column was further washed with the 200 ml 
solution containing 50 mM Tris-HCl, pH 8.0 and 25 mM imidazole. His6-tagged 
protein was eluted with the other buffer solution (50 mM Tris-HCl, pH 8.0 and 
400 mM imidazole). The collected His6-tagged protein was subjected to dialysis 
against 50 mM sodium phosphate buffer, pH 6.0. After the dialysis, 80-unit 
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thrombin protease solution (GE Healthcare) was put into the protein solution 
to cleave the His6-tag from the PPIase domain fragment; the proteolysis 
reaction was done at 20°C for overnight. The reactant was applied to 
cation-exchanger column HiTrap SP FF (GE Healthcare) equilibrated with 50 
mM sodium phosphate buffer, pH 6.0. PPIase domain was eluted by the NaCl 
gradient from 0 M to 1 M in 50 mM sodium phosphate buffer, pH 6.0, using 
BioLogic DuoFlowTM HPLC system (Bio-Rad). The collected fractions 
containing PPIase were subjected to the extensive dialysis against the desired 
buffer solutions according to the purposes for use.  
Site directed mutation to change C113 to D113 in Pin1 PPIase domain was 
done by using KOD FX (TOYOBO). The purification of C113D mutant PPIase 
was carried out according to the same protocol described for the wild-type 
PPIase. 
  
2-2. NMR spectroscopy and structure determination 
  The structural determination of the wild-type and C113D PPIases were done 
according to the standard procedure using isotope labeled samples [146]. A set 
of standard 3D triple-resonance data was used to assign backbone and side 
chain resonances. NOEs from 15N edited and 13C edited 3D NOESY spectra 
were used to generate the distance restraints in the structure calculation. All 
NMR data were got on a Bruker AvanceII spectrometer equipped with a triple 
resonance cryogenic probe operating at 700.33 MHz for 1H resonance frequency. 
Samples concentrations for wild-type and C113D were both 0.8 mM, in 50 mM 
sodium phosphate (pH 6.6), 100 mM Na2SO4, 1 mM DTT, 0.03% NaN3 and 5 
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mM EDTA. In the case of the samples in 50 mM Tris-HCl (pH 6.8), 1mM DTT, 
and 0.03% NaN3 contained 0.3 mM protein for both the wild-type and the 
C113D mutant PPIases. All experiments were done at 299 K. NMR data were 
processed by NMRPipe [147], and the spectral analyses were done using the 
program suite KUJIRA [148] running with NMRview [149].  
Structure calculation was carried out by the program CYANA 2.1 for fully 
automatic NOE assignments [150, 151]. The backbone dihedral angle 
restraints were generated by the TALOS+ program [152]. The 40 
lowest-energy CYANA structures were subjected to explicit water refinement 
with XPLOR-NIH [153] with the distance and dihedral restraints. The final 10 
XPLOR-NIH structures were validated using the program PROCHECK-NMR 
[154]. The structural statics for both wild-type and C113D mutant PPIase 
domains in the presence of sulfate and phosphate ions are provided in table 
II-1.  
The resonance assignments and the structural data for the wild-type and 
C113D mutant PPIase domains in the presence of sulfate and phosphate ions 
are deposited in the Biological Magnetic Resonances Bank (BMRB) and the 
Protein Data Bank (PDB): BMRB accession codes: 11559 and 11560, PDB 
accession codes: 2RUC and 2RUD. BMRB accession codes for wild-type and 
C113D mutant PPIases in the absence of sulfate and phosphate ions are 11557 
and 11558. 
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2-3. Isothermal titration calorimetry (ITC) experiments 
  ITC experiments were carried out at two temperatures, 288 K and 298 K, on 
a Microcal Auto-iTC200 calorimeter (GE Healthcare). Cdc25C peptide 
(sequence: EQPLpTPVTDL, pT represents a phosphorylated threonine) was 
dissolved in 50 mM Tris-HCl buffer solution (pH 6.8). The peptide was titrated 
into a 200 μl PPIase solution (0.1 mM protein centration, 50 mM Tris-HCl, pH 
6.8); 1.5 μl of peptide solution (1.2 mM concentration) was injected at each of 
the total 25-time titrations. The collected data were analyzed through the 
software Microcal ORIGIN (GE Healthcare). Cdc25C phosphorylated peptide 
was purchased from a company (Funakoshi) and used without further 
purification.  
 
2-4. Isomerization rate measurements  
  Isomerase activities for wild-type and C113D mutant PPIases were assessed 
by using 2D 1H-1H EXSY (EXchange SpectroscopY) [138, 155]. The sample 
contained 2 mM Cdc25C phosphopeptide with 50 μM PPIase, wild-type or 
C113D. The sample solution contained 50 mM Tris-HCl (pH 6.8), 1 mM DTT, 
and 0.03% NaN3. The experiments were done at 295 K on a 700 MHz NMR 
spectrometer. The exchange times were set to 2, 5, 10, 15, 25, 35, 50 (twice), 75, 
100 (twice), 200, 300, and 400 ms. The net exchange rate, kEX, was estimated 
to fit the equation below (eq. 1) to the ratios of the trans-to-cis exchange 
cross-peaks against the trans diagonal peaks. In estimating the kEX values, the 
buildup profiles from the signals for pT5 CH3, pT5 HN and V7 HN were 
simultaneously used for fitting, as in a global fitting manner. 
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                                              (1)                                      
 
In eq 1, kCT and kTC are the adjustable parameters in fitting and the net 
exchange rate, kEX, is defined as kEX = kCT + kTC, where kCT and kTC are the 
exchange rates from cis-to-trans and trans-to-cis, respectively. Uncertainties in 
the rate constants were estimated by using Monte Carlo simulations based on 
the duplicated data.  
 
2-5. NMR spin relaxation experiments and analysis 
  All backbone 15N R1 and R2 relaxation rates and steady-state heteronuclear 
15N NOE (hNOE) data were collected at 700 MHz NMR spectrometer at 299 K. 
Samples had 1.4 mM (wild-type) and 2.0 mM (C113D mutant) protein, 
respectively, in 50 mM sodium phosphate (pH 6.6), 5 mM EDTA, 100 mM 
Na2SO4, 1 mM DTT, and 0.03% NaN3. In the case of the samples in 50 mM 
Tris-HCl (pH 6.8), 1mM DTT, and 0.03% NaN3 contained 0.3 mM protein for 
both the wild-type and the C113D mutant PPIases. Each peak intensity was 
measured by averaging over the signal intensities at the peak center and its 
eight surrounding points (9-point averaging); each peak center was found by 
SPARKY ‘pc’ function (T.D. Goddard and D.G. Kneller, SPARKY 3, University 
of California, San Francisco). The delays for R1 measurements were trelax = 10.3 
(twice), 153.9, 307.9, 461.8, 615.7 (twice), 769.6, 923.6, 1128.8, 1539.3 ms, 
while the delays for R2 were trelax = 0.0, 16.0 (twice), 40.0, 80.0 (twice), 160.0 ms. 
The spectra for R1 and R2 were collected in an interleaved manner. For 
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measuring hNOEs, we recoded an interleaved pair of spectra in which 1H 
saturation of 3 s was applied alternatively with the relaxation delay set to 2 s. 
  R1 and R2 relaxation rate constants for each signal were determined through 
the function fitting using modelXY TCL built-in function of NMRPipe. 
Uncertainties for R1 and R2 were estimated in a Monte Carlo manner based on 
the duplicated data. The uncertainty for each hNOE value was evaluated 
using the root mean square deviation (rmsd) value on the spectral area having 
no peaks, which was gained by the NMRPipe built-in module. 
  The reduced spectral density functions including Jeff(0), J(ωh), J(ωN) were 
calculated using the software suites, REALAX version 3.1.5 [156, 157]. 
Rotational correlation times and the rotation diffusion tensors for the 
wild-type and C113D mutant were determined by using the program package 
RotDif [158] on Matlab platform (Mathworks). 
  
2-6. H/D exchange rate measurements 
  The amide proton-deuteron exchange (H/D exchange) rates were measured 
with extensively lyophilized samples; the sample solution (wild-type or C113D 
mutant PPIase in 50 mM sodium phosphate, pH 6.6, 5 mM EDTA, 100 mM 
Na2SO4, 1 mM DTT, and 0.03% NaN3) was rapidly frozen by liquid nitrogen, 
then put into a vacuum chamber for about 12 h. To remove remaining protons 
from the sample, the above lyophilized sample was again dissolved by 100 μL 
D2O (over 99.96 atom % deuterium; Sigma-Aldrich) and again lyophilized. The 
lyophilized sample in a plastic test tube was dissolved by the same volume of 
D2O as that evaporated, just prior to a series of 2D 1H-15N HSQC spectra. 
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NMR measure was initiated within 10 min after dissolving the sample. For the 
case of the wild-type, one spectrum was collected for 25 min and 24 data were 
collected sequentially. For the C113D mutant, it took 35 min for one spectrum 
and the 35 spectra were measured sequentially. There were no apparent 
structural changes caused by lyophilize to both wild-type and C113D PPIases, 
which was evidenced by the NMR spectral comparison between the data before 
and after lyophilization. H/D exchange rate for each peak was determined 
through the peak intensity change according to the measuring time; time at 
the end of each spectral collection was used as the H/D exchange delay time for 
the signals on the corresponding spectrum. In functional fitting to extract the 
H/D exchange rate, H DR ! , the incomplete 1HN exchange to 2DN due to the 
residual protons content in D2O solution was considered; the function in eq. 2 
was, thus, used for fitting to the HN intensity profile; 
                                           (2) 
where I0, Ib, and H DR ! are used as the adjustable parameters in fitting 
calculation. 
 
2-7. R2 relaxation dispersion experiments 
  Conformational exchange rates were further elucidated by using R2 
relaxation dispersion experiments using a series of 15N CPMG-HSQC spectra 
[159]. The effective transverse relaxation rates were measured by changing 
the delays between 180° pulses for 15N spins in CPMG loop. Total CPMG 
duration was kept constant at 40 ms. Samples contained 1.4 mM (wild-type) 
and 2.0 mM (C113D mutant) protein, respectively, in 50 mM sodium phosphate 
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(pH 6.6), 5 mM EDTA, 100 mM Na2SO4, 1 mM DTT, and 0.03% NaN3. In the 
case of the samples in 50 mM Tris-HCl (pH 6.8), 1mM DTT, and 0.03% NaN3 
contained 0.3 mM protein for both the wild-type and the C113D mutant 
PPIases. All the experiments were carried out at 299 K on a Bruker AvanceII 
700 MHz NMR spectrometer. Each peak intensity was estimated by the 
nine-point averaging for each cross peak with a home-written program.  
 Kinetic parameters were estimated by using a two-state model of the 
general Carver-Richards equation [160]. Functional fitting to the data was 
achieved by using a home-written program adopting the differential evolution 
optimization [161]. Uncertainties were estimated on the basis of duplicate data 
and Monte-Carlo approach, in which 32 data sets of each residue were 
generated based on an initial fit of the collected data to which Gaussian noise 
representing experimental uncertainties of R2 was added. Exchanging 
residues were grouped according to their individual R2 rates, and the residues 
in each group were subjected to the global fitting to gain the single R2 value for 
all the residues in the same group. Uncertainty for the global kinetic 
parameter was estimated by Monte-Carlo approach.  
 
2-8. Measuring histidine imidazole 15N chemical shift changes according to 
the D2O content in solution  
  The imidazole 15N chemical shifts were measured using 1H-15N HSQC 
spectra for the sample solution containing 6%, 50% and 100% D2O. The sample 
was prepared from the lyophilized protein solution with 50 mM sodium 
phosphate buffer (pH 6.6) and 100 mM sodium sulfate. To exclusively 
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eliminate the proton, the lyophilized sample was dissolved by D2O and then 
subjected to further lyophilization; the procedure was repeated twice to 
extensively purge protons in the sample. In the final sample solution 
containing different amount of D2O, 5 mM EDTA, 1 mM DTT and 0.03% NaN3 
was added. All data were collected at 299 K on a 700 MHz NMR spectrometer.  
 
2-9. Circular Dichroism (CD) spectroscopy to monitor the heat denaturing 
processes of the wild-type and C113D mutant 
  The molar ellipticity at 222 nm was performed to monitor the structural 
denaturing process with a JASCO-720W spectrometer. Sample solution was 
consists of 50 mM sodium phosphate (pH 6.0), 100 mM Na2SO4, and 1 mM DTT. 
Protein concentration was adjusted to 2 μM for the cases of the wild-type and 
C113D mutant. Temperature was changed in the range of 20°C to 80°C, with 
increasing rate at 1°C/min.  
 
2-10. Maleimide assay for reactivity analyses of the cysteine residues in 
Pin1 
  Maleimide assay was performed as described previously [162]. Briefly, 
proteins (2 μg) were incubated with various concentration of hydrogen 
peroxide (H2O2) in the presence of 1mM TCEP for 30 min at room temperature. 
Oxidation reaction was terminated by adding TCEP and SDS for the final 
concentration of 1 mM and 0.5%, respectively. Then, rhodamine-maleimide 
(Life Technologies) was added to the mixture to 0.2 mM final concentration, 
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and incubated at room temperature for 30 min. The reaction was stopped by 
adding SDS-PAGE sample buffer containing β-mercaptoethanol, and proteins 
were separated by SDS-PAGE. Rhodamine fluorescence was visualized by 
image reader, RAS4000 (Fujifilm, Tokyo Japan). 
 
2-11. Mass spectroscopic analyses of the oxidized peptides in Pin1 
  The wild-type Pin1 was incubated with 0.01% hydrogen peroxide in the 
presence of 1 mM TCEP for 30 min at room temperature. Proteins were 
separated from reaction ingredients by desalting column, PD-10 (GE 
healthcare). After proteins had been completely digested by trypsin, peptides 
were analyzed by LTQ (Thermo Fisher Scientific) and MASCOT search engine 
(Matrix Science). 
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3. Results 
3-1. Cis-trans isomerization rates for wild-type and C113D mutant PPIases 
 C113D mutant Pin1 PPIase showed significant reduction in kcat relative to 
the wild-type [128]. To further elucidate the role of C113 in the isomerization 
process, we directly measured the cis-trans isomerization rates for the 
wild-type and C113D mutant PPIase domains using 2D EXSY (Figure II-2A). 
In the following description, we refer to Pin1 PPIase domain as simply PPIase, 
unless otherwise noted. Cdc25C phosphorylated peptide was used as substrate. 
The cis-to-trans isomerization rates were 51.6 ±1.9 s-1 (wild-type) and 0.7 ± 0.5 
s-1 (C113D mutant) at 295 K. The rates for trans-to-cis exchange were 6.6 ± 2.1 
s-1 (wild-type) and 0.1 ± 0.0 s-1 (C113D mutant). The isomerase activity of 
C113D was approximately 70-fold lower than that of the wild-type. 
 
3-2. C113D mutant PPIase had limited affinity to the phosphorylated 
peptide 
  The binding affinity to phosphorylated peptide was compared with ITC 
(Figure II-2B). The results demonstrated that C113D mutant PPIase has very 
limited affinity to the phosphor-peptide, apparently no binding ability was 
observed; while the wild-type showed the dissociation constant KD ~ 10 mM. 
The reduced isomerization rate of C113D mutant is ascribed to its faint 
substrate affinity.  
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3-3. Induced structural change by C113D mutation assessed by NMR 
chemical shifts  
  Comparison of 2D 1H-15N HSQC spectra for the wild-type (Figure II-3A) and 
C113D mutant (Figure II-3B and II-3B-1) PPIases showed C113D mutation 
caused spectral change to a wide-range of residues in the catalytic site (Figure 
II-4A). Residues K63, R68, and R69 showed significant structural changes, 
implying the mutation may disturb the distal loop in an allosteric manner 
(Figure II-4A, right).  
  S114 and S115, which neighboring to the mutation site, showed a severe 
reduction in their signal intensities (Figure II-4B); the signal for S114 in 
C113D was observed at 8.80 ppm (1H) and 120.6 ppm (15N) (Figure II-3B-1) on 
the spectrum with extremely weak intensity, whereas the S115 signal was not 
observed. C113D substitution could facilitate their amide proton exchanges 
with water by proximate positioning of the negatively charged aspartate side 
chain to the amide groups of S114 and S115 [163].  
 
3-4. Structural changes caused by C113D mutation 
  Three dimensional structures for the wild-type and C113D mutant were 
solved by NMR under the same experimental condition (Figure II-5). The 
overlaid structures for the wild-type and C113D PPIases demonstrated the 
apparent structural changes are in the helix near the mutation site, and the 
active site loop (residues K63-T81) (Figure II-6A). In the followings, the 
observed structural differences will be described in detail.   
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  The structures near the C113 showed subtle but significant changes; the 
short helix including S114 and S115 was extended in C113D (Figure II-6B). 
The extended helix could make the amide groups in S114 and S115 stay close 
to the side chain negative charge of D113 in longer residence time than that  
for the corresponding residues in the wild-type, which may explain the reduced 
signal intensities for S114 and S115 in C113D (Figure II-4B).  
  In closer looking at the active site loop (residues K63-T81) in C113D mutant, 
the backbone structure changed from the corresponding part in the wild-type 
to disorient the side chains of the residues K63, R68 and R69, which are called 
as “basic triad” (Figure II-6C). The crystal structure of a reduced amide-Pin1 
complex (PDB code: 3NTP), which structure is considered to mimic the 
transition state complex with pSer-Pro, the residues in the basic triad have 
hydrogen bonds to the phosphate moiety in the substrate [84]. The side chain 
disorientation of the basic triad in C113D mutant may explain the severely 
reduced binding to the phosphorylated substrate (Figure II-2B).  
  To support the above discussion on the C113D active loop structure, it should 
be noted that the active loop keeps the structural rigidity comparable to the 
secondary structured parts, as evidenced by the hNOE values greater than 0.8, 
in both the wild-type and C113D mutant (Figure II-12). The structural change 
observed for the loop is, therefore, significant (Figure II-6C): in general, the 
accuracy and precision for a segment in NMR structure tend to be spoiled, if 
the segment has apparent structural flexibility indicated by low hNOE values 
(typically, < 0.5), but it is not the case for this loop. 
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  The structural determination of the wild-type and C113D mutant PPIases 
were finished in the solution containing 50 mM sodium phosphate and 100 mM 
Na2SO4. In the sample solution, phosphate or sulfate ions should stay in the 
phosphate binding pocket formed by the basic triad in both the wild-type and 
C113D mutant; which were evidenced by the chemical shift changes between 
the spectra for the proteins in solution with (Figure II-3) and without (Figure 
II-7) phosphate and sulfate ions (Figure II-8). The basic triad structures in the 
present wild-type and C113D mutant (Figure II-6C) could surrogate the 
phosphor-moiety bound state, which may consolidate the functional 
significance of the structural changes in the basic triad.  
  The C113D mutation destabilized the neighboring histidine cluster 
comprising of H59 and H157: the number of NOEs from histidine ring protons 
have significantly reduced in C113D relative to the wild-type (Figure II-6D). 
Although the spatial arrangement of the imidazole rings of H59 and H157 in 
C113D is close to that in the wild-type, their side chain dynamics should be 
increased in the mutant. NOE intensity depends not only on the inter-proton 
distance but also the internal motion to fluctuate the inter-proton distance; if 
the fluctuation on the inter-proton distance is significant, the observed NOE 
intensity for a coupled protons should be reduced [164].  
 
3-5. Histidine hydrogen bond stabilities elucidated using H/D isotope effect 
on NMR chemical shifts  
  In accordance with the destabilization to histidine cluster in the active site, 
C113D mutation perturbed the hydrogen bonds mediated by H59 and H157, 
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which was evidenced by using H/D isotope effect on the 15N chemical shifts for 
their ring moieties. The direct attachment of deuteron to 15N atom changes the 
15N chemical shifts according to the “hydron” (referring to proton or deuteron) 
position in the hydrogen bond; the secondary isotope effect is defined as 
, where (DN)G  and (HN)G  denote the 15N chemical shift 
values when bonded to deuteron and proton, respectively [165].  
  The tautomeric forms for H59 and H157 in Pin1 PPIase were determined by 
1H-15N HSQC using 1Hε1 and 1Hδ2 in imidazoles [166]; H59 Nε2 and H157 Nδ1 
were directly bound to proton (Figure II-9). The 15N chemical shifts for Nε2 
(H59) and Nδ1 (H157) showed high-field isotope shifts by binding to deuteron 
(Figure II-10). The identified tautomeric forms for the histidine imidazole 
rings were used in the structure calculation to define their ring orientation 
(Figure II-6D). The imidazole ring flips for H59 and H157 were the same 
between the wild-type and C113D mutant Pin1 PPIase; their ring orientations 
were similar to those found in the high-resolution Par14 crystal structure [126]. 
As expected from the Par14 structure, the hydrogen bonds between Hε2 (H59) 
and Hδ1 (H157) can form hydrogen bonds to C113 (D113) side chain Sγ (Oδ) 
atom and H59 Nδ1, respectively.  
  The stability of each hydrogen bond was elucidated based on the chemical 
exchange rates between the ND and NH states in the solution containing 50% 
D2O (Figure II-10). As demonstrated in the parts of the spectra, the signal 
shapes for Nε2 (H59) and Nδ1 (H157) observed in 50% D2O solution were 
different between the wild-type and C113D mutant, implying the hydrogen 
bonds in the histidine cluster changed in C113D mutant active site (Figure 
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II-10). The Nδ1 (H157) in the wild-type PPIase was doublet along the 15N axis, 
whilst the counterpart signal in the C113D mutant was singlet resonating at 
the mid of the chemical shifts between δ(Nδ1H) and δ(Nδ1D ) (Figure II-10A). In 
the case of the Nε2 (H59), the wild-type showed singlet but the C113D mutant 
show doublet signal (Figure II-10B). The doublet signals in 50% D2O solution 
indicates the slow H/D exchange onto the corresponding 15N nucleus; based on 
the isotope shift of δ(15N) around -1.0 ppm (Figure II-10), the H/D exchange 
rate for the proton on the 15N nucleus showing double is estimated less than 
155 s-1. The 15N imidazole nitrogen atoms showing doublet should be engaged 
in the stable hydrogen bonds.  
  The imidazole ring orientations determined in the wild-type and C113D 
mutant could assure the hydrogen bond network connecting the residues 
C113/D113-H59-H157-T152, is formed across the active site irrespective of 
mutation, as found in Par14 crystal structure [126]. In assuming the hydrogen 
bond network, 15Nε2 (H59) doublet in the C113D mutant may indicate a stable 
hydrogen bond is formed between D113 Oδ and H59 Hε2 in C113D, while 15Nδ1 
(H157) doublet indicates the stable hydrogen bond formed by Hδ1 (H157) to Nδ1 
of H59 in wild-type with reducing the stability of the hydrogen bond by Hε2 
(H59) to C113 side chain oxygen, Sγ.  
 
3-6. C113D reduced structural stability as evidenced by enhanced amide 
H/D exchange 
  The residue-specific amide H/D exchange rates were measured from a 
sequentially collected 1H-15N HSQC spectra for both the wild-type and C113D 
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mutant. The exchange rates were determined for all the residues observed on 
the first 1H-15N HSQC spectrum just after pouring D2O into the lyophilized 
sample powder. Most of the residues in C113D mutant showed enhanced H/D 
exchange rates relative to the wild-type (Figure II-11), implying C113D mutant 
PPIase structure is less stable than the wild-type.  
 
3-7. Comparing the reduced spectral density maps between the wild-type 
and C113D mutant 
 To further characterize the structural dynamics change caused by C113D 
mutation, we compared the reduced spectral density functions [167]. The 
reduced spectral density functions, Jeff(0), J(ωh), and J(ωN), can be mapped for 
each residue with the rates R1 and R2 with hNOE for 15N spin, under the 
approximation to equate the high-frequency values of the spectral density 
function J(ωH) = J(ωH-ωN) = J(ωH+ωN) [167]. The spectral density function J(ωH) 
is denoted as J(ωh) in the reduced form, to implicate the above approximation 
[167]. The reduced spectral density function Jeff(0) denotes that, since chemical 
exchange is not considered explicitly in its derivation. The entire profiles for 
the reduced spectral densities are compared (Figures II-13 and Figures II-14). 
  The difference in the Jeff(0) values between the wild-type and C113D mutant 
are plot along the residue number; each difference was calculated as ΔJeff(0) = 
Jeff(0)[C113D] – Jeff(0)[wild-type] (Figure II-15). The most of the residues in 
C113D showed larger Jeff(0) values than those for the corresponding residues 
in the wild-type (Figure II-15). This allosteric destabilization effect by C113D 
seems rather independent on the presence of the phosphate group in the 
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pocket, as the residues in the active loop showed increased Jeff(0) in the mutant 
in the solution with or without phosphate and sulfate ions (Figure II-15). In 
general, Jeff(0) dominates R2 relaxation rate, while hNOE is very sensitive to 
both changes in internal motion described by the correlation time, τi, and the 
generalized order parameter, S2. Assuming the internal motion of protein 
backbone is too fast and, thus, independent from the overall rotational motion 
represented by the correlation time, τc, the simple model-free formalism [168] 
gives the spectral density function as described below, eq. 3. 
      
                                             (3) 
 
The spectral density function of J(0) is, thus, described as in eq. 4.  
                                             (4) 
The spectral density function J(0) is dependent on S2, τi, and τc, when the 
chemical exchange is negligible.  
  The transverse relaxation rate R2 contains the rates governed by the nuclear 
spin-spin relaxation process ( 2DDR ), chemical shift anisotropy of 15N nuclear 
spin ( 2CSAR ), and chemical exchange process ( exR ) [167]; 
                                              (5) 
  Chemical exchange apparent in the backbone 15N spin relaxation process 
implies that the backbone conformational exchange happening in msec time 
regime [167].  
  It is noted that, in deriving the reduced spectral density functions, Rex term 
is neglected in the R2 function in eq. 5. However, Jeff(0), not the other J(ωh) and 
J(ωN), depends on R2 rate and if the chemical exchange rate, Rex, is significant,  
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the corresponding Jeff(0) value increases accordingly [167]. The hNOE profiles 
for the wild-type and C113D mutant PPIase are close to each other (Figure 
II-12), implying that C113D mutation does not apparently affect the structural 
dynamics in ns – ps time range; τi, and S2 values for the residues in C113D 
mutant are be very close those for the counterpart residues in the wild-type. 
The rotational correlation time, τc, was estimated for each the wild-type and 
C113D mutant, in considering rotational diffusion anisotropy [158]: they were 
τc = 9.4 ± 0.4 ns with rotational diffusion tensor anisotropy 1.3 ± 0.1 (wild-type) 
and τc = 9.5 ± 0.5 ns with the anisotropy 1.2 ± 0.1 (C113D mutant). In both 
cases, the axially symmetric rotational diffusion tensor model was adopted 
with statistical significance. As estimated above, the correlation time, τc, does 
not change by the C113D mutation. The changes in the dynamics parameters  
τc, τi, and S2 are marginal to explain the observed differences in Jeff(0), in 
considering the model-free function J(0) in eq. 4. The increased Jeff(0) values 
for the residues in C113D mutant, therefore, can be traced to the increased 
chemical exchange terms for R2 rate (eq. 5); which implies that most part in 
C113D mutant becomes structurally unstable to show significant 
conformational exchange apparent in msec time regime.  
  The changes in Jeff(0) values are particularly apparent for the residues in the 
phosphate binding pocket, especially residues 60–75 (Figure II-15A right), 
suggesting the binding pocket becomes structurally unstable in C113D mutant. 
The higher frequency reduced spectral density functions, J(ωh) and J(ωN), did 
not show any noticeable changes in their values induced by the mutation, 
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although those changes were dependent on the existence of phosphate and 
sulfate ions (Figures II-16 and Figures II-17).  
  R2 relaxation dispersion experiments were applied to further characterize 
the structural dynamics in ms time domains. However, the results were less 
informative due to the limited number of the residues having detectable R2 
dispersion profiles, as described in the preceding work (Table II-2) [169]. It is 
noted that the changes in the structural dynamics revealed by the R2 
dispersion profiles were dependent on the co-existence of the phosphate and 
sulfate ions (Table II-2); the number of residues showing significant R2 
dispersion increased in both the wild-type and C113D in the absence of the 
ions.  
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4. Discussion 
4-1. C113D mutation disarranges the basic triad in active loop of Pin1 
PPIase domain  
  This work has demonstrated that C113D mutation destabilizes the catalytic 
site fold in Pin1 PPIase domain, which resulted in the allosteric change in the 
loop structure having the basic triad comprising of K63, R68 and R69. Among 
the basic triad, R69 showed the largest difference in the side chain orientation 
C113D mutant relative to the wild-type (Figure II-6C). The basic triad makes 
hydrogen bonds to phosphate moiety, as shown in the crystal structures [84, 
113]. The molecular dynamics simulation of Pin1 in the complex with 
phosphorylated peptide demonstrated that the basic triad kept binding to 
substrate during isomerization; in particular, R69 and K63 form tighter 
interactions to phosphate group, while R68 is less crucial [144]. Therefore, 
disordering the basic triad structure, especially R69 side chain reorientation, 
explains the severely reduced substrate binding ability of C113D mutant, 
which was evidenced by the ITC experiments in this work (Figure II-2B).  
  C113D mutation reduces the isomerization rate for the Cdc25C 
phosphor-Ser peptide by 70-fold (Figure II-2A). In considering the above ITC 
experiments, the reduced isomerase activity of C113D mutant can be 
explained by its lowered affinity to the substrate. Since the first Pin1 crystal 
structure was reported, the role of SH group in C113 has been focused [128, 
154]. These earlier proposals emphasizing the role of SH group as a catalyst in 
the cis–trans isomerization are now called into questions due to the several 
controversial results; one of which is the fact that C113D mutant does not 
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abolish its isomerization activity [128]. The present work demonstrated that 
C113 roles in keeping the catalytic site of PPIase in active fold, in particular, to 
maintain the functionally primed form of the basic triad.  
 
4-2. Catalytic site fold was destabilized by C113D mutation  
  The allosteric structural change to the active loop could be propagated 
through the catalytic tetrad including C113, H59, H157, and T152 (Figure 
II-6D). The residues in the catalytic tetrad may form the hydrogen bonding 
network, as found in the crystal structure of Par14 [126]. In the present NMR 
analyses, no direct experimental validation was done to confirm the hydrogen 
bonding network. However, we could deduce the corresponding hydrogen 
bonding network exists in the catalytic site of PPIase for both the wild-type 
and C113D, because the defined imidazole ring flips for H59 and H157 and the 
spatial surrounding of C113/D113 and T152 in the NMR structures resemble 
the catalytic tetrad structure in Par14 (Figure II-6D). The hydrogen bonding 
network runs across the catalytic site of PPIase to connect the short helix 
having C113/D113 to the opposite side near the active loop.  
  The overall structure of C113D was similar to the wild-type structure 
(Figure II-6A), but the structural stability of C113D was significantly lower 
than that of the wild-type, as evidenced by the heat denaturing experiments 
(Figure II-18); the melting temperatures for the wild-type and C113D mutant 
were 49.4°C and 46.2°C, respectively. In addition, the less number of NOEs 
from imidazole rings of H59 and H157 in the catalytic site of C113D mutant 
 43 
 
relative to the wild-type implicates the increased structural flexure of the 
histidines in the catalytic site (Figure II-6D).  
  In the mid of the catalytic tetrad, there are two conserved histidines, H59 
and H157, which is referred to as “dual histidine motif”. The dual histidine 
motif is important for keeping the Pin1 fold; H59L mutation destabilized the 
protein, thus resulted in the faint isomerization activity [170]. Our study has 
shown that C113D mutation changed the strengths of the hydrogen bonds from 
H59 and H157 (Figure II-10). In the C113D mutant, H59 imidazole has a 
stronger hydrogen bond presumably to D113 side chain oxygen, whilst H59 has 
a tighter hydrogen bond to H157 imidazole in the wild-type, which were 
elucidate using H/D isotope effect on imidazole 15N of the histidines (Figure 
II-10). The change in hydrogen bond is reminiscent of “tug-of-war” for H59 
between the C113/D113 and H157 (Figures II-19A and II-19B). In considering 
the pivotal role of H59 in maintaining catalytic site fold, it is plausible that the 
imbalance in the tug-of-war for H59 in C113D mutant destabilizes the 
structure.  
  The sulfur atom in the SH moiety is a poor hydrogen bond acceptor [171]. 
The change from SH to OH group, therefore, strengthens the hydrogen bond 
between D113 and H59 Nε2 in C113D mutant with simultaneously weakening 
the hydrogen bond between H59 and H157 imidazole (Figures II-19A and 
II-19B). The weakened inter-histidine hydrogen bond in C113D mutant is 
consistent with the increased imidazole ring dynamics as shown by the 
decreased number of NOEs from the rings (Figure II-6D).  
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4-3. Allosteric structural change in the active site loop by C113D mutation   
  The allosteric structural change in the active loop, which disorganized the 
basic triad, could be probably caused by the reduced folding stability of the 
catalytic site. The reduced structural stability by C113D mutation was 
experimentally confident; the increased H/D exchange rates for the residues 
constituting the catalytic site (Figure II-11), and the elevated conformational 
exchange as elucidated by the increased values of Jeff(0) (Figure II-15), in 
particular the residues 59 to 75 were apparent. The induced structural 
flexibility for the residues near H157 is also noticeable (Figures II-15).  
 
4-4. C113 is sensitive to oxidation and C113D mimics the oxidized form 
Pin1 
  Pin1 PPIase domain has two cysteine residues, C57 and C113. The structure 
shows C57 is buried in the structure while C113 SH moiety is exposed to the 
solvent. As expected C113 has higher sensitivity to oxidation; the H2O2 
oxidized specifically modified to C113, as assayed using maleimide 
fluorescence labeling and mass spectroscopy (Figure II-20). The excessive 
oxidation to SH group produces sulfonic acid group that structurally resembles 
carboxylic acid group as D113 in C113D mutant (Figure II-20). The C113D 
mutant could be supposed to mimic the oxidized form of Pin1 PPIase domain 
that happens inside cells under oxidative stress [133, 172]. The present study 
suggests the oxidized form of Pin1 PPIase domain reduces the binding activity 
to substrate, thus, has lowered isomerization activity.  
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5. Conclusions 
  In Chapter II, the present work has demonstrated a novel role of C113 in 
stabilizing the catalytic site fold. The change from SH to OH group disturbs 
the hydrogen bonding network formed by the catalytic tetrad because of 
unbalancing the tug-of-war for H59 between the residues at 113 and 157 
(Figure II-19). Dual histidine motif comprising of the conserved H59 and H157 
is important for keeping the catalytic site in an active fold. The imbalance of 
the tag-of-war in C113D mutant weakens the hydrogen bond among the dual 
histidine motif, thus destabilizes the catalytic site fold. The disturbed 
hydrogen bonding network in the catalytic tetrad leads to the allosteric 
disorder of the active loop including basic triad that binds to a phosphate 
moiety in the substrate, which explains the reduced substrate binding ability 
of C113D mutant. Pin1 oxidation happening in cells should reduce its 
isomerization activity through the alleviated binding to substrate, as 
anticipated from the work on C113D mutant PPIase domain being supposed to 
be a surrogate for the oxidized form of Pin1 PPIase domain. 
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Figure II-1 
(A) Nucleophilic addition mechanism is proposed from complex crystal structure of 
Pin1 and Ala-Pro peptide (PDB: 1PIN) [113]. Red: covalent bond between thiol of 
C113 and carbonyl carbon in the catalytic process. (B) Catalytic activity was 
measured for wild-type, C113D, and C113S [128]. Substrate: WFYpSPR-pNA.  
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Figure II-2 
(A) Experimental rate constants for the wild-type and C113D mutant were measured by 
EXSY with Cdc25C phosphorylated peptide at varying exchange times. (B) Isothermal 
titration calorimetric data for the wild-type (left) and C113D mutant (right) PPIase 
domains at 298 K. Each peak corresponds to 1.5 μl injection of Cdc25C phosphorylated 
peptide substrate solution. The red full line drawn in the wild-type ΔH plot (left bottom) is 
the best-fit model function assuming 1:1 protein–substrate stoichiometry.  
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Figure II-3 
Backbone resonance assignment for PPIases drawn on the 1N-15N HSQC spectrum with 
ions. (A) wild-type, amide groups of 109 residues (95.61%) were assigned except four 
prolines and E30. (B) C113D mutant, amide groups of 108 residues (94.74%) were 
assigned except four prolines, E30, and S115. (B-1) Backbone resonance assignment for 
residues in the box of (B).  
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Figure II-4 
(A) Residue-wise plot for the normalized chemical shift differences between the wild-type 
and C113D mutant in the presence of sulfate and phosphate ions. The normalized 
chemical shift difference for each residue is defined as, 1 2 15 2( H) ( N/ 5)G G G'  '  ' , 
where Δδ1H and Δδ15N are the chemical shift difference in 1H and 15N dimensions, 
respectively [173]. According to the magnitude of Δδ, the residues in the C113D mutant 
structure were colored differently: over Δδave + 1 σ (red), over Δδave + 0.5σ (purple), and 
over Δδave + 0.25 σ (yellow), where Δδave is the average value for Δδ and σ is the standard 
deviation of Δσ calculated over the entire residues. (B) The overlaid presentation of the 
parts of the 1H-15N spectra for the wild-type (black) and C113D mutant (red) in the 
presence of sulfate and phosphate ions, which show the signals for S114 (left) and S115 
(right) have disappeared on the spectrum for C113D mutant. The S114 signal was 
observed far from the displayed spectral region with very weak intensity while the S115 
resonance was not observed in anywhere on the spectrum for C113D mutant. 
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Figure II-5 
(A) Three dimensional solution structure for wild-type PPIase domain. (B) Three 
dimensional solution structure for C113D mutant PPIase domain. Obvious structural 
changes could be observed between wild-type and C113D mutant PPIase domains.  
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Figure II-6 
(A) Structure overlap between the wild-type (gray) and C113D mutant (cyan) PPIase 
domains determined in this work. (B) Close up view of the structures near the mutation 
site of the wild-type (left, gray) and C113D mutant (right, cyan). (C) The active loop 
structure comprising of the basic tetrad, K63, R68 and R69; the wild-type (left, gray) and 
C113D mutant (right, cyan). (D) The observed NOEs from the imidazole ring protons are 
drawn in yellow lines; the wild-type (left) and C113D (right). All figures were built by the 
program PyMOL (Schrödinger, LLC).  
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Figure II-7 
Backbone resonance assignment for PPIases drawn on the 1N-15N HSQC spectrum 
without ions. (A) wild-type, amide groups of 109 residues (95.61%) were assigned except 
four prolines and E30. (B) C113D mutant, amide groups of 107 residues (93.86%) were 
assigned except four prolines, E30, S114, and S115.  
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Figure II-8 
Plot of the normalized chemical shift differences for the backbone chemical shifts between 
the presence and absence of sulfate and phosphate ions. (A) The wild-type and (B) C113D 
mutant. According to the magnitude of the normalized chemical shift difference, which is 
defined as 1 2 15 2( H) ( N/ 5)G G G'  '  ' , where Δδ1H  and Δδ15N are the chemical shift 
difference in 1H and 15N dimensions, respectively, the residues in the wild-type and C113D 
mutant PPIase domain structures were colored differently (right): over Δδave + 1 σ (red), 
over Δδave + 0.5σ (purple), and over Δδave + 0.25 δ (yellow), where Δδave is the average value 
for Δδ and σ is the standard deviation of Δσ calculated over the entire residues. 
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Figure II-9 
1H-15N HSQC spectra for the imidazole rings of histidines in Pin1. (A) The wild-type and 
(B) C113D mutant. A set of signals marked with asterisks come from the histidine residue 
at position 0 in the segment comprising of GSH sequence, which was attached to the 
N-terminus due to the reason of plasmid construction 
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Figure II-10 
H/D isotope effects on the chemical shifts for 15N nuclei in the histidine imidazole ring 
were measured in the solutions having different D2O contents. (A) The 1H-15Nδ1 HSQC 
signals for H157 collected in the solution containing 6% (black, left), 50% (blue, middle), 
and 100% (red, right); data in the upper and lower panels are for the wild-type and C113D 
mutant, respectively. (B) The same data set for 1H-15Nε2 signals for H59 of the wild-type 
(upper) and C113D mutant (lower).  
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Figure II-11 
H/D exchange rates for the residues in the wild-type (black) and C113D (red) mutant. The 
residues without exchange rates showed no observable peaks on the first 1H-15N HSQC 
spectrum in a series of data collection, implying their amide protons have rapidly 
exchanged to deuterons within about 10 min.  
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Figure II-12 
Heteronuclear NOE (hNOE) values plot against the residue number. (A) wild-type, (B) 
C113D mutant. The value marked with an asterisk is less reliable because the residue 
showed very small signal intensity even under non-saturating condition. (A) and (B) were 
finished in the presence of sulfate and phosphate ions. (C) wild-type, (D) C113D mutant. 
(C) and (D) were finished in the absence of sulfate and phosphate ions. 
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Figure II-13 
The comparison of the reduced spectral density function values of Jeff(0), J(ωN), and J(ωh) = 
J(ωH) = J(ωH-ωN) = J(ωH+ωN) for the data collected in the presence of sulfate and phosphate 
ions. The bars in red are data for the C113D mutant, and the black bars are those for the 
wild-type. 
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Figure II-14 
The comparison of the reduced spectral density function values of Jeff(0), J(ωN), and J(ωh) 
for the data collected in the absence of sulfate and phosphate ions. The bars in red are 
data for the C113D mutant and the black bars are those for the wild-type.  
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Figure II-15 
The residue-wise difference plot for Jeff(0) for the data collected in the presence of sulfate 
and phosphate ions (A) and in the absence of the ions (B). Δ Jeff(0) was calculated from the 
value for C113D mutant minus that for the wild-type. The difference was calculated for 
each residue as 113(0) (0) (0)C D wild typeeff eff effJ J J '    , where Jeff(0)C113D and Jeff(0)wild-type the 
values for C113D mutant and the wild-type, respectively. The residues in the C113D 
mutant structure are colored according to the magnitude of the ΔJeff(0) value; over 
ΔJeff(0)ave + 1σ (red), over ΔJeff(0)ave + 0.5σ (magenta), less than ΔJeff(0)ave - 1σ (blue) and 
less than ΔJeff(0)ave – 0.5σ (cyan).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 78 
 
 
 
 
                                    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 79 
 
Figure II-16 
The residue-wise difference plot for J(ωN) for the data collected in the presence of sulfate 
and phosphate ions (A) and in the absence of the ions (B). ΔJ(ωN) was calculated from the 
value for C113D mutant minus that for the wild-type. 
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Figure II-17 
The residue-wise difference plot for J(ωh) for the data collected in the presence of sulfate 
and phosphate ions (A) and in the absence of the ions (B). ΔJ(ωh) was calculated from the 
value for C113D mutant minus that for the wild-type. 
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Figure II-18 
The heat induced protein denaturing measured by CD molar ellipticity at 222 nm. Blue 
line indicates the profile for the wild-type Pin1 PPIase domain, while the red line is for 
C113D mutant. 
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Figure II-19 
Hydrogen bonding network and the tag-of-war for H59. (A) The wild-type PPIase domain, 
H59 forms stronger hydrogen bond to H157. (B) In the C113D mutant, H59 strengthen the 
hydrogen bonding to C113 with weakening the hydrogen bond to H157. (C) Oxidation to 
Pin1 PPIase preferentially converts C113 thiol group to sulfonate moiety, which resembles 
D113 side chain structure. Oxygen atom in sulfonate group plays as a better hydrogen 
bond acceptor than the sulfur atom in thiol of C113. The oxidized C113 would strengthen 
the hydrogen bond from H59 with weakening hydrogen bond between H59 and H157, as 
in C113D mutant. The oxidized Pin1 would be inactivated to the comparable level of 
C113D mutant Pin1.  
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Figure II-20 
Oxidation of the cysteine residues in Pin1. (A) Complete oxidation of a thiol group of 
cysteine leads to forming cysteic acid. The difference in the mass between them should be 
forty-eight corresponding to three oxygen. (B) Maleimide assay revealed the preferred 
reactivity of C113 in Pin1. Cysteine modification blocked the labeling of Pin1 proteins by 
rhodamine-maleimide. Increasing amount of H2O2 blocked the maleimide labeling of Pin1 
(right). C113 in C57A mutant protein showed more sensitive (left), but C57 in C113D 
mutant protein showed less sensitive to oxidation (center). (C) Mass spectroscopic 
analysis revealed the existence of cysteic acid at the position of C113 in H2O2-treated Pin1. 
In the control peptide, C113 showed 103 molecular mass in MS/MS analysis (upper panel). 
On the contrary, in the H2O2-treated Pin1 protein, corresponding C113 showed 151 
suggesting the formation of sulfonic acid as shown in A. 
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Table II-1 
 
Structural statistics of the each final 10 structures of the wild-type (WT) and C113D mutant 
(C113D) PPIase domains of human Pin1 
 
   WT   C113D 
RMSDs from NOE upper distance restraints (Å)   
Intra-residual (|i-j| = 0) (539 for WT, and 540 for C113D)      0.000±0.004 0.000 ± 0.010 
Medium-range (1 ≤ |i-j| ≤ 4) (1140, and 969)                 0.006 ± 0.048 0.008 ± 0.052 
Long-range (|i-j| > 4) (1062, and 881)                      0.012 ± 0.069 0.013 ± 0.088 
Total (2741, and 2390) 0.007 ± 0.053 0.008 ± 0.063 
RMSDs from dihedral angle restraints (M and \) (°)  
(88 for WT, and 82 for C113D)a 0.068 ± 0.178 0.143 ± 0.396 
RMSDs from ideal stereochemistry   
Bonds (Å) 0.005 ± 0.000 0.005 ± 0.000 
Angles (º) 0.510 ± 0.007 0.534 ± 0.010 
Impropers (º) 0.793 ± 0.052 0.776 ± 0.040 
Ramachandran plotb (%)   
Residues in most favored regions 87.1 87.8 
Residues in additional allowed regions 12.8 11.8 
    Residues in generously allowed regions 0.1 0.3 
Residues in disallowed regions 0.0 0.1 
Average RMSDs to the mean structure (Å)c   
Backbone  (N,CA,C’,O) 0.68 ± 0.15 0.74 ± 0.16 
All non-hydrogen 1.18 ± 0.19 1.23 ± 0.21 
 
a The angle restraints were from TALOS+ with the angle ranges ±30°. 
 
b For the residues R54-R161 in the 10 lowest energy structures. 
 
c For the residues in the secondary structured parts (residues R54-V62, K82-K97, F103-Q109,  
 
 S114-A118, D121-S126, K132-S138, V150-F151, and G155-R161 for wild-type, and R54-V62, 
  
 K82-K97, F103-Q109, S114-A118, A124-S126, K132-F139, M146-F151, and G155-R161 for  
  
 C113D mutant, respectively).  
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Table II-2 
 
Conformational exchange in Pin1 PPIase domains for the wild-type and C113D mutant 
 
Sample Residues in a Group a Rex / sec-1 b 
Wild-type 
(with ions) 
C57 651 ± 48 
E104 
F125 
T143 
Wild-type 
 (without ions) 
C57 1099 ± 154 
E83 
Q94 
E104 
F134 
T143 
C113D mutant  
(with ions)  
C57 773 ± 71 
Q94 
T143 
C113D mutant 
(without ions) 
LF c Q94 710 ± 63 
E104 
T143 
D153 
HF c C57 1660 ± 124 
R69 
E83 
F125 
M130 
Q131 
 
a The residues in a group were subjected to the global fitting to determine the unique Rex value for the 
grouped residues. 
 
b Values of Rex were calculated from the fits of data to the Caver-Richards equation in the 
fast-exchange regime.  
 
c The residues in the C113D mutant were classified into two classes showing different conformation 
exchange; LF and HF are the groups comprising the residues showing the higher- and lower 
conformational exchange rate, respectively. 
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 Chapter III 
 General conclusions 
1. C113D mutant with partial cis-trans isomerization rate is against 
nucleophilic attack mechanism  
  In nucleophilic attack mechanism for human Pin1 PPIase domain, C113 
sulfur will form covalent bond to the carbonyl carbon of the substrate to 
facilitate the isomerization process. It is known that the carboxyl group of 
D113 in C113D mutant does not form covalent bond with the carbonyl carbon, 
however, our work shows that C113D mutant still has partial cis-trans 
isomerization rate, not the abolished catalytic function. This phenomenon is 
against previous proposed nucleophilic attack mechanism. In twisting amide 
bond mechanism, C113 sulfur was suggested to be far from methylene carbon 
in transition state. However, twisting amide bond mechanism did not show the 
role of C113 in the catalytic process. The present work has shown that C113 
has a role in maintaining the catalytic site in an active fold, challenging the 
catalytic role of C113 in the catalytic process. In C113D mutant, the binding 
pocket residues show the allosteric changes and the active loop reveals reduced 
structurally stability, indicating decreased binding ability for the peptide, 
which may explain the decreased cis-trans isomerization rate. 
  
2. Oxidized Pin1 in Alzheimer’s disease 
  Our work has shown that C113D mutant mimics the oxidized form of Pin1. 
Oxidized Pin1 is proposed to have the reduced catalytic activity which is 
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ascribed to the low binding ability for substrate. Tau protein is one substrate of 
Pin1 in the cells and tau is hyper-phosphorylated and accumulated in 
Alzheimer’s disease [134], which was thought to be related with oxidized Pin1 
[172]. It is speculated that oxidized Pin1 loses the binding ability for tau 
protein and thus cannot isomerize tau protein, which induces the tau protein 
to be abnormal formation in Alzheimer’s disease. 
  C113D mutant shows a reduced structural stability that is evidenced by H/D 
exchange and CD spectrum experiments. It is proposed that the oxidized Pin1 
also has reduced structural stability; thus, the hydrophobic region of oxidized 
Pin1 has the higher possibility to be exposed to solvent relative to wild-type. 
Hydrophobic area of oxidized Pin1 is prone to interact with each other to form 
the accumulation compared with wild-type. Previous study showed that Pin1 
was observed to be accumulated that may be related with Alzheimer’s disease, 
although the role of accumulation was still elusive [174]. Hence, our work 
provides new insights into the Pin1 accumulation mechanism in the 
Alzheimer’s disease.  
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